Search - tctmd.com

Displaying 381 - 400 of 584

Sort: Relevancy | Date

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Presentation TCT 2013

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Presenter: Magdi El-Omar, Sorin Brener, Akiko Maehara, Thomas Scott, Roxana Mehran, Wim Aengevaeren, Dariusz Dudek, Martin Fahy, C. Michael Gibson, Gregg Stone

January 31, 2013

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Presentation TCT 2013

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Presenter: Akiko Maehara, Gary Mintz, Sorin Brener, Jan-Henk Dambrink, Magdi El-Omar, Anthony Gershlick, Martin Fahy, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter?

Presentation TCT 2012

Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter?

Presenter: C. Michael Gibson

October 25, 2012

Optimizing Adjunct Pharmacotherapy Before, During, and After PCI: An Evidence-Based Tutorial

Presentation TCT 2012

Optimizing Adjunct Pharmacotherapy Before, During, and After PCI: An Evidence-Based Tutorial

Presenter: C. Michael Gibson

October 25, 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Rivaroxaban Update: ATLAS-ACS-2 TIMI-51: Recent Analyses and FDA Redux

Presentation TCT 2012

Rivaroxaban Update: ATLAS-ACS-2 TIMI-51: Recent Analyses and FDA Redux

Presenter: C. Michael Gibson

October 24, 2012

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Presentation TCT 2012

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Presenter: C. Michael Gibson

October 24, 2012

Strategies for the ACS Patient with Chronic Atrial Fibrillation

Presentation TCT 2012

Strategies for the ACS Patient with Chronic Atrial Fibrillation

Presenter: C. Michael Gibson

October 24, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

March 26, 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presentation PCI Outcomes 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presenter: C. Michael Gibson

March 23, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

Video

»

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

September 21, 2022

Video

» Conference Wrap-Up

TCT 2022 Day 3 Wrap-Up

September 19, 2022

Video

» Interview

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

September 19, 2022

Video

» Interview

A Randomised Controlled Trial Assessing The Value CTCA In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous CABG Undergoing Invasive Coronary Angiography

September 18, 2022

Video

» Conference Wrap-Up

TCT 2022 Day 2 Wrap-Up

September 18, 2022

Video

» Interview

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

September 18, 2022

Video

» Interview

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

September 18, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.